Federated Hermes’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,900
| Closed | -$407K | – | 2272 |
|
|
2020
Q1 | $407K | Buy |
12,900
+12,423
| +2,604% | +$392K | ﹤0.01% | 1434 |
|
|
2019
Q4 | $28K | Sell |
477
-1,412
| -75% | -$82.9K | ﹤0.01% | 1798 |
|
|
2019
Q3 | $69K | Buy |
1,889
+725
| +62% | +$26.5K | ﹤0.01% | 1691 |
|
|
2019
Q2 | $54K | Buy |
+1,164
| New | +$54K | ﹤0.01% | 1663 |
|
|
2017
Q2 | – | Sell |
-10
| Closed | -$1K | – | 2136 |
|
|
2017
Q1 | $1K | Sell |
10
-114
| -92% | -$11.4K | ﹤0.01% | 2055 |
|
|
2016
Q4 | $2K | Sell |
124
-29,731
| -100% | -$480K | ﹤0.01% | 2006 |
|
|
2016
Q3 | $413K | Sell |
29,855
-5,364
| -15% | -$74.2K | ﹤0.01% | 1334 |
|
|
2016
Q2 | $348K | Buy |
+35,219
| New | +$348K | ﹤0.01% | 1369 |
|
|
2015
Q4 | – | Sell |
-12,000
| Closed | -$283K | – | 2102 |
|
|
2015
Q3 | $283K | Buy |
12,000
+6,000
| +100% | +$142K | ﹤0.01% | 1427 |
|
|
2015
Q2 | $491K | Hold |
6,000
| – | – | ﹤0.01% | 1334 |
|
|
2015
Q1 | $556K | Buy |
+6,000
| New | +$556K | ﹤0.01% | 1336 |
|